FG allays fears over AstraZeneca vaccine

0
1179

The federal government of Nigeria in a bid to allay the the fears of Nigerians disclosed that 8,000 nationals have been given the Covid-19 vaccine so far, including President Muhammadu Buhari and Vice President Yemi Osinbajo, and none has reported any adverse effect since the vaccination began last week.

A number of countries have suspended the rollout of the AstraZeneca vaccine due to concerns over reported negative effects.

The federal government has however assured Nigerians of its safety.

It said no case of side effects of the vaccine such as blood clotting has so far been reported in the country.

The number of countries that have suspended AstraZeneca vaccine increased yesterday with France, Germany, Spain and Italy joining the long list.

But the World Health Organisation (WHO) advised countries using the vaccine to continue with its rollout.

The Executive Director of National Primary Healthcare Development Agency (NPHCDA), Dr. Faisal Shuaib, also said over 8,000 Nigerians had been vaccinated without any single report of serious adverse effect.

Shuaib said: “As part of COVID-19 vaccine launch, which commenced last week across the country, over 8,000 Nigerians have been immunised so far. We have not received any official report of serious adverse effects from any of those who have been vaccinated.”

Minister of Health, Dr. Osagie Ehanire, at the media briefing by the Presidential Taskforce on the Control of COVID-19 on Monday March 15, in Abuja, said the Federal Ministry of Health was impressed by the cooperation received from Nigerians since the commencement of the vaccination.

He stated, “I am pleased to say that their excellencies, the president and vice president, as well as strategic leaders who have taken the vaccine along with frontline healthcare workers, are all doing very well.”

He added: “I assure everyone that the vaccine is safe. NAFDAC is collaborating with WHO, manufacturers and partners to evaluate other vaccines and also add to our portfolio of vaccines.”